SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-24-000155
Filing Date
2024-07-30
Accepted
2024-07-30 08:04:27
Documents
16
Period of Report
2024-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-20240730.htm   iXBRL 8-K 35155
2 EX-99 pfe-6302024xex99.htm EX-99 937789
7 pfizerlogo.jpg GRAPHIC 38679
  Complete submission text file 0000078003-24-000155.txt   1254021

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20240730.xsd EX-101.SCH 2737
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20240730_def.xml EX-101.DEF 15360
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20240730_lab.xml EX-101.LAB 27449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20240730_pre.xml EX-101.PRE 16027
18 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20240730_htm.xml XML 4452
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 241154449
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)